Press release
The next decade to see the Neuropathic Pain Market reverberate digitally at a CAGR of 6%
Reaching the revenues of over US$ 6 Bn at the end of 2019, the global neuropathic pain management market is projected for a healthy CAGR during the forecast period (2019 - 2029). Increasing prevalence of neuropathic pain disorders and growing awareness about pain medication are boosting the demand for pain management drugs.
Planning Forward? Access Sample Of Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/samples/4149
Pipeline strategies by manufacturers are focused on introducing advanced drugs with minimum side effects to increase market share. For instance, Pfizer sponsored drug Pregabalin, effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma that is in phase 3 clinical trials. Increasing research and development activities to develop medications for indications such as post-herpetic neuralgia are creating significant opportunities for manufactures to flourish in the market.
Company Profiles:
Pfizer Inc.
Johnson & Johnson Services, Inc.
Bristol-Myers Squibb Company
Sanofi S.A
GlaxoSmithKline plc
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd
Baxter International Inc
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Neuropathic Pain Market? https://www.persistencemarketresearch.com/methodology/4149
Key Takeaways - Neuropathic Pain Management Market Study
Attributed to less side effects, tricyclic antidepressant drugs are expected to be popular as compared to opioids and steroids during the forecast period.
North America is expected to be significant revenue generator owing to emergence of several regional market players and well-developed healthcare infrastructure.
Retail pharmacies are expected to be dominant distribution channels in the neuropathic pain management market.
Increasing prevalence of diabetic neuropathy and availability of approved neuropathy pain medications have significantly added to the opportunities for market growth, thereby fostering the rate of adoption of neuropathic pain management drugs.
Planning To Introduce An Offbeat Product/Technology In The Neuropathic Pain Market? Go To "Purchase Now" To Have Our Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/checkout/4149
Increasing R&D Spending by Pharmaceuticals Companies Shaping Future
One of the key factors observed to impact the neuropathic pain management market growth is the development of new drugs for treatment of neuropathic and chronic pains. Companies are focusing on clinical trials to develop drugs for efficient treatment of neuropathic pain. For instance, Eli Lilly and Company developed Duloxetine (LY248686) for Diabetic Peripheral Neuropathic Pain (DPNP) that is under phase 4 clinical trial.
At the same time, companies are focused on expanding therapeutic applications of drugs such as opioids and steroids for neuropathic pain management without causing any serious side effects to patients. Currently, more than 100 clinical trials are been carried out for pain management. Among those clinical trials, nearly half of the clinical trials are for various indications of neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/neuropathic-pain-market.asp
What Does the Report Cover?
The neuropathic pain management market, a new study from Persistence Market Research, provides unparalleled insights on evolution of the neuropathic pain management market during 2014 - 2018 and presents demand projections during 2019 - 2029 on the basis of drug class (tricyclic anti-depressants, anticonvulsants, SNRI's, capsaicin cream, local anesthesia, opioids, steroids, and others), indication (diabetic neuropathy, trigeminal neuralgia, post-herpetic neuralgia, chemotherapy-induced peripheral neuropathy and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies) across prominent regions (North America, Latin America, Europe, Asia Pacific and MEA).
Related Reports:
Cutaneous And Systemic Leishmaniasis Market - https://www.persistencemarketresearch.com/market-research/cutaneous-and-systemic-leishmaniasis-market.asp
Cutaneous Fribrosis Treatment Market - https://www.persistencemarketresearch.com/market-research/cutaneous-fribrosis-treatment-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The next decade to see the Neuropathic Pain Market reverberate digitally at a CAGR of 6% here
News-ID: 2622578 • Views: …
More Releases from Persistence Market Research
Global Memory Market Set for Strong Growth Driven by AI and Data Centers
The global memory market is entering one of its most transformative growth cycles in decades. As digital ecosystems scale rapidly across artificial intelligence (AI), cloud computing, data centers, automotive electronics, and edge devices, memory technologies are becoming the backbone of modern computing infrastructure. From high-performance servers to connected vehicles and IoT endpoints, memory capacity, speed, and efficiency now directly influence system performance and competitiveness.
The global memory market size is likely…
Why Network Traffic Analyzers Are Becoming Critical for Modern Enterprises
The global digital ecosystem is undergoing an unprecedented transformation as enterprises, governments, and service providers become increasingly dependent on high-performance, always-on networks. In this environment, understanding how data flows across networks is no longer optional-it is mission-critical. Network traffic analyzers have emerged as essential tools that enable organizations to monitor, inspect, and optimize network performance while defending against escalating cyber risks.
The global network traffic analyzer market is likely to be…
Storage Adapter Market Accelerates with High-Speed Data and Cloud Demand
The storage adapter market plays a critical role in modern IT infrastructure by enabling seamless communication between servers and storage systems. Storage adapters-such as host bus adapters (HBAs), RAID controllers, and converged network adapters-are essential for managing high-speed data transfer, low latency, and reliable connectivity across enterprise data centers, cloud platforms, and hyperscale environments. As data volumes surge and workloads become more complex, storage adapters have evolved from basic connectivity…
Pregelatinized Starch Market US$2.4 Bn by 2033 Driven by Food Processing Demand
The global pregelatinized starch market is poised for consistent growth over the coming years, supported by rising demand across food processing, pharmaceuticals, paper, textiles, and other industrial applications. In 2026, the global pregelatinized starch market size is expected to be valued at approximately US$ 1.7 billion. With increasing adoption across both developed and emerging economies, the market is projected to reach around US$ 2.4 billion by 2033. This growth trajectory…
More Releases for Neuropathic
Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Inte …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%;…
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
